The $6 Billion Shot at Making New Antibiotics
Antimicrobials cost as much to develop as other drugs, but don’t earn the same returns. Congress could give drugmakers a boost, but time is running out.
Stay updated with breaking news from Pasteur Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Antimicrobials cost as much to develop as other drugs, but don’t earn the same returns. Congress could give drugmakers a boost, but time is running out.
The Pasteur Act could save so many lives. The question is, will it be passed? In the US, antibiotic innovation has been put on hold, and the last novel class that the FDA approved was in 1984, according to Wired.
Commentary Hospital rooms, operating rooms, and medical equipment are so inadequately cleaned that any patient going into a ...
Beating back the superbugs starts with hospitals cleaning up.
A hospital patient who contracts a superbug faces a far higher risk of death than another patient with the same medical